Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy
Franciele Hinterholz Knebel(Institute of Cancer Research), Marco Gerlinger(Royal Marsden NHS Foundation Trust)
Cited by 7
Related Papers
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
|Journal for ImmunoTherapy of Cancer|2019|114
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1